Highlights
MWC technical excellence helps NZ attract new medicines
A high profile paper has highlighted the growing support the MWC is providing to NZ’s burgeoning clinical trials sector.
read the full story
MWC continues to lead the way in NZ cancer vaccine research
Immune therapy is one of the most exciting and promising areas of cancer research. Around New Zealand, teams of Maurice Wilki...
read the full story
MWC senior leadership team welcomes new appointees
We highlight the recent appointments of three exceptional scientists – Associate Professor Rinki Murphy, Professor Debbie Hay...
read the full story
Cancer drug advances to phase II clinical trials
A New Zealand cancer drug developed by two Maurice Wilkins Centre investigators has reached the second phase of clinical tria...
read the full story
Partnerships boost business: MWC supports Auckland Clinical Studies (2013)
The Maurice Wilkins Centre provides world-class support for medical trials provider Auckland Clinical Studies, helping to cem...
read the full story
New chemistry transforms cancer vaccine (2013)
A new kind of chemistry that dramatically simplifies the manufacture of cancer vaccines was created this year by Honours stud...
read the full story
Stepping up the fight: The Tuberculosis Flagship (2013)
The Maurice Wilkins Centre is behind the launch of a national research network of ‘serious intellectual muscle’ that aims to ...
read the full story
New Zealand TB drug candidate selected (2012)
In late 2012 a promising New Zealand compound targeting treatment-resistant tuberculosis (TB) was selected as a drug candidat...
read the full story
A licence to manufacture medicines (2012)
A licence to manufacture medicines has been granted to a University of Auckland facility that will produce the active ingredi...
read the full story